Revenue Growth YoY (Last 12 Months): heartbeam.com (BEAT)

Graphic logo of HeartBeam Corporation (BEAT)

HeartBeam, Inc. (BEAT) success is based on the implementation of mobile 3D-ECG systems and FDA approval. This trailing twelve-month revenue chart reflects the dynamics of this process, where the current value is 0.00. A team of top-tier engineers is creating life-saving tools, while unique patents for myocardial infarction diagnostics form a technological foundation that will strengthen upon mass adoption by physicians.

BEAT - HeartBeam Corp Sales Growth YoY (TTM) over the range 02/11/2024 - 11/18/2026

HeartBeam Inc (BEAT) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company valuation:BEAT HeartBeam Corp
Flagship merchandise of HeartBeam

This metric measures revenue dynamics over the last twelve months relative to the same period last year, revealing the business's operational resilience to demand fluctuations. By analyzing this rolling year-over-year revenue growth chart, one can assess the commercialization of HeartBeam, Inc. (BEAT) ECG systems following FDA approvals. The positive trend confirms the successful implementation of telemedicine solutions within hospital networks, while steady growth guarantees investors a capital safety margin.